Inventor · disambiguated record
Mark D. Hylarides
Also filed as: HYLARIDES MARK D
14 granted patents·4 pending applications·392 citations·filing 1984–2008
94Inventor score
Top patents by PatentIndex Score
18 records- 0192US5563250ACleavable conjugates for the delivery and release of agents in native formNEORX CORP·Filed 1994·Granted Oct 8, 1996·146 cites·3 claims
- 0290US6767531B2High dose radionuclide complexes for bone marrow suppressionNEORX CORP·Filed 2001·Granted Jul 27, 2004·29 cites·13 claims
- 0388US7070759B2High dose radionuclide complexes for bone marrow suppressionNEORX CORP·Filed 2005·Granted Jul 4, 2006·9 cites·29 claims
- 0487US7696331B2High dose radionuclide complexes for bone marrow treatmentPONIARD PHARMACEUTICALS INC·Filed 2008·Granted Apr 13, 2010·7 cites·9 claims
- 0585US7378077B2High dose radionuclide complexes for bone marrow suppressionPONIARD PHARMACEUTICALS INC·Filed 2006·Granted May 27, 2008·6 cites·16 claims
- 0685US6358710B1Humanized antibodies that bind to the antigen bound by antibody NR-LU-13NEORX CORP·Filed 1997·Granted Mar 19, 2002·59 cites·7 claims
- 0784US7097823B2High dose radionuclide complexes for bone marrow suppressionNEORX CORP·Filed 2004·Granted Aug 29, 2006·13 cites·10 claims
- 0881US5141648AMethods for isolating compounds using cleavable linker bound matricesNEORX CORP·Filed 1991·Granted Aug 25, 1992·66 cites·13 claims
- 0976US7408046B2Treatment of bone-associated cancersPONIARD PHARMACEUTICALS INC·Filed 2004·Granted Aug 5, 2008·6 cites·20 claims
- 1065US4577046ADeamination of aromatic aminesUNIV NEW MEXICO·Filed 1984·Granted Mar 18, 1986·8 cites·23 claims
- 1164US2009094715A1Methods of use of antibodies with reduced immunogenicity or toxicityPONIARD PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 1263US5017693AMethods for introducing a sulfhydryl amino or hydroxyl groups to a compoundNEORX CORP·Filed 1989·Granted May 21, 1991·27 cites·10 claims
- 1363US2005100545A1Methods of use of antibodies with reduced immunogenicity or toxicityNEORX CORP·Filed 2003·Application pending·0 cites
- 1462US2005008635A1Humanized antibodies that bind to the antigen bound by antibody NR-LU-13 and their use in pretargeting methodsNEORX CORP·Filed 2004·Application pending·0 cites
- 1556US2003119078A1Method of reducing immunogenicity of toxicity of an antibody of IgG classNEORX CORP·Filed 2002·Application pending·0 cites
- 1650US5911969APretargeting protocols for enhanced localization of active agents to target sitesNEORX CORP·Filed 1994·Granted Jun 15, 1999·10 cites·9 claims
- 1746US4676932ASynthesis of 1-haloestradiolsUNIV NEW MEXICO·Filed 1984·Granted Jun 30, 1987·5 cites·3 claims
- 1832US4584137ASynthesis of 1-haloestradiolsUNIV NEW MEXICO·Filed 1984·Granted Apr 22, 1986·1 cites·25 claims
Join the waitlist — get patent alerts
Get an alert when Mark D. Hylarides files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →